Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020)
Open Access
- 24 February 2021
- Vol. 26 (5), 1202
- https://doi.org/10.3390/molecules26051202
Abstract
The remarkable prevalence of pyrazole scaffolds in a versatile array of bioactive molecules ranging from apixaban, an anticoagulant used to treat and prevent blood clots and stroke, to bixafen, a pyrazole-carboxamide fungicide used to control diseases of rapeseed and cereal plants, has encouraged both medicinal and organic chemists to explore new methods in developing pyrazole-containing compounds for different applications. Although numerous synthetic strategies have been developed in the last 10 years, there has not been a comprehensive overview of synthesis and the implication of recent advances for treating neurodegenerative disease. This review first presents the advances in pyrazole scaffold synthesis and their functionalization that have been published during the last decade (2011–2020). We then narrow the focus to the application of these strategies in the development of therapeutics for neurodegenerative diseases, particularly for Alzheimer’s disease (AD) and Parkinson’s disease (PD).Keywords
Funding Information
- National Institutes of Health (NS075527, NS103957, NS103988, U19NS110456)
This publication has 155 references indexed in Scilit:
- Oxidative Stress and the Pathogenesis of Alzheimer's DiseaseOxidative Medicine and Cellular Longevity, 2013
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s diseaseActa Neuropathologica, 2013
- Synthesis and in vitro biological evaluation of pyrazole group-containing analogues for PDE10AMedChemComm, 2012
- Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's diseasePharmacology & Therapeutics, 2011
- Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's diseaseBritish Journal of Pharmacology, 2011
- DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activityThe Journal of cell biology, 2011
- APP processing in Alzheimer's diseaseMolecular Brain, 2011
- Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxibChemico-Biological Interactions, 2010
- Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau PathologyJournal of Neuroscience, 2009
- Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: Synthesis and in vitro evaluationBioorganic & Medicinal Chemistry Letters, 2007